Prothena Corporation plc (PRTA)
NASDAQ: PRTA · Real-Time Price · USD
8.20
-0.05 (-0.61%)
At close: Oct 23, 2026, 4:00 PM EDT
9.10
+0.90 (10.98%)
After-hours: Oct 23, 2026, 7:30 PM EDT
Prothena Corporation Employees
Prothena Corporation had 67 employees as of December 31, 2025. The number of employees decreased by 96 or 58.90% compared to the previous year. That makes Prothena Corporation the 33,812th largest employer in the world and 4,457th in the United States.
Employees
67
Change (1Y)
-96
Growth (1Y)
-58.90%
Revenue / Employee
$813,881
Profits / Employee
-$656,597
Market Cap
420.96M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 67 | -96 | -58.90% |
| Dec 31, 2024 | 163 | -10 | -5.78% |
| Dec 31, 2023 | 173 | 46 | 36.22% |
| Dec 31, 2022 | 127 | 45 | 54.88% |
| Dec 31, 2021 | 82 | 16 | 24.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 754 |
| ProKidney | 231 |
| ARS Pharmaceuticals | 200 |
| Assembly Biosciences | 73 |
| TRex Bio | 60 |
| Tectonic Therapeutic | 60 |
| Altimmune | 57 |
| Zura Bio | 40 |
PRTA News
- 6 weeks ago - Prothena to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - Business Wire
- 2 months ago - Prothena Reports Second Quarter 2026 Financial Results and Business Highlights - Business Wire
- 2 months ago - Prothena Corporation Earnings release: Q2 2026 - Filings
- 2 months ago - Prothena Corporation Quarterly report: Q2 2026 - Filings
- 2 months ago - Prothena Corporation Slides: Corporate presentation - Filings
- 2 months ago - Prothena to Report Second Quarter 2026 Financial Results on August 6 - Business Wire
- 5 months ago - Prothena price target raised to $20 from $19 at Citizens - TheFly
- 5 months ago - Prothena cuts FY26 net cash used view to $18M-$23M from $50M-$55M - TheFly